Epub 2009 Mar 16
After consideration of public comments, based on CY 2024 claims data available for this final rule with comment period, we are finalizing our proposal to designate six brachytherapy APCs and five clinical APCs as low volume APCs under the OPPS
They are commonly used for conditions like cervical radiculopathy, spinal stenosis, and disc disorders
Because 5-amino-1MQ is not a compounding-pharmacy-accessible substance and is not an FDA-approved therapy, the safety discussion is primarily about what physicians should tell patients asking about it, rather than about clinical monitoring parameters for active therapy
This research-grade lyophilized powder is produced under strict quality standards and includes full analytical documentation, making it suitable for in-vitro oxidative stress, redox signaling, and detoxification pathway research
Tip: Train your staff to recognize modifier requirements